The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
- PMID: 32470514
- PMCID: PMC7250564
- DOI: 10.1016/j.jacc.2020.05.041
The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials
Keywords: COVID-19; pandemic; randomized controlled trials.
References
-
- McDermott M.M., Newman A.B. Preserving clinical trial integrity during the coronavirus pandemic. JAMA. 2020 Mar 25 [E-pub ahead of print] - PubMed
-
- National Institutes of Health UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19). Notice document. March 26, 2020. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-091.html Available at:
-
- U.S. Food and Drug Administration FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency. Guidance document. March 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents... Available at:
MeSH terms
LinkOut - more resources
Full Text Sources
Medical